novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

RE-DUAL PCI – Study in NVAF patients undergoing PCI – João Morais (English version)

13 Novembro 2017

João Morais

Tags:
João Morais

Introdução

13 Novembro 2017
0

Oral anticoagulants. A definite change in our practice - Jan Steffel

15 Novembro 2017
0

-->